Alliance Against Cancer, the network of Italian cancer centers bridging research and care

Journal of Translational Medicine

Commentary

Francesco De Lorenzo¹  Manlio Ferrarini²  Paolo De Paoli³  Pellegrino Musto⁴  Alberto Mantovani⁵  Paolo Dellabona⁶  PierGiuseppe Pelicci⁷  Gennaro Ciliberto⁸  Giuseppe Opocher⁹  Piero Picci^1,10  Walter Ricciardi^1,11  Ruggero De Maria^1,12 

[1] Associazione Italiana Malati di Cancro (AIMaC), Rome, Italy;Azienda Ospedaliera-Universitaria San Martino-IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy;Centro di Riferimento Oncologico (CRO), IRCCS, Istituto Nazionale Tumori, Via Franco Gallini 2, 33081, Aviano, PN, Italy;Centro di Riferimento Oncologico della Basilicata (CROB) IRCCS, Rionero in Vulture, PZ, Italy;Humanitas University, Istituto Clinico Humanitas, MI, Rozzano, Italy;IRCCS Ospedale San Raffaele, Milan, Italy;Istituto Europeo di Oncologia (IEO), Milan, Italy;Istituto Nazionale Tumori, Fondazione Pascale, IRCCS, Naples, Italy;Istituto Oncologico Veneto, IOV IRCCS, Padua, Italy;Istituto Ortopedico Rizzoli, IRCCS, Bologna, Italy;Istituto Superiore di Sanità, Rome, Italy;Regina Elena National Cancer Institute, Rome, Italy;

关键词: Italy;    Network of cancer centers;    Translational research;    Cancer care;    Personalized medicine;    Clinical trials;   

DOI  :  10.1186/s12967-015-0711-x

 received in 2015-09-30, accepted in 2015-10-23,  发布年份 2015

来源: Springer

【 摘 要 】

Alliance Against Cancer (ACC) was established in Rome in 2002 as a consortium of six Italian comprehensive cancer centers (Founders). The aims of ACC were to promote a network among Italian oncologic institutions in order to develop specific, advanced projects in clinical and translational research. During the following years, many additional full and associate members joined ACC, that presently includes the National Institute of Health, 17 research-oriented hospitals, scientific and patient organizations. Furthermore, in the last three years ACC underwent a reorganization process that redesigned the structure, governance and major activities. The present goal of ACC is to achieve high standards of care across Italy, to implement and harmonize principles of modern personalized and precision medicine, by developing cost effective processes and to provide tailored information to cancer patients. We herein summarize some of the major initiatives that ACC is currently developing to reach its goal, including tumor genetic screening programs, establishment of clinical trial programs for cancer patients treated in Italian cancer centers, facilitate their access to innovative drugs under development, improve quality through an European accreditation process (European Organization of Cancer Institutes), and develop international partnerships. In conclusion, ACC is a growing organization, trying to respond to the need of networking in Italy and may contribute significantly to improve the way we face cancer in Europe.

【 授权许可】

CC BY   
© De Paoli et al. 2015